C4 Therapeutics, Inc.
CCCC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662579
No open-market purchases or sales by C4 Therapeutics, Inc. insiders were filed in the last 90 days; 147 institutions reported holding it in 13F filings for Q2 2026, worth $547.6M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding C4 Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 102 | 97 | −5 |
| Shares | 54.7M | 52.5M | −2.15M (−3.9%) |
| Value | $78.2M | $116.6M | +$38.4M (+49.1%) |
New holders (21)
Institutions that held C4 Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Silverarc Capital Management, LLC | 1,897,383 | $4.21M | 0.61% |
| Citadel Advisors LLC | 481,449 | $1.07M | 0.00% |
| Shay Capital LLC | 420,000 | $932.4K | 0.17% |
| Qube Research & Technologies Ltd | 115,973 | $257.5K | 0.00% |
| Algert Global LLC | 106,300 | $236.0K | 0.00% |
| Marshall Wace, LLP | 106,275 | $235.9K | 0.00% |
| State of Wyoming | 82,509 | $183.2K | 0.02% |
| Graham Capital Management, L.P. | 40,628 | $90.2K | 0.00% |
| Jefferies Financial Group Inc. | 38,200 | $84.8K | 0.00% |
| Voleon Capital Management LP | 28,420 | $63.1K | 0.00% |
| American Century Companies Inc | 24,248 | $53.8K | 0.00% |
| Caitong International Asset Management Co., Ltd | 19,146 | $42.5K | 0.03% |
| Prudential Financial Inc | 14,300 | $31.7K | 0.00% |
| Zacks Investment Management | 13,043 | $29.0K | 0.00% |
| Wolverine Trading, LLC | 12,710 | $28.3K | 0.00% |
| Simplicity Wealth,LLC | 10,213 | $22.7K | 0.00% |
| Simplex Trading, LLC | 7,836 | $17.0K | 0.00% |
| JFS Wealth Advisors, LLC | 1,000 | $2.22K | 0.00% |
| Wealthspire Advisors, LLC | 100 | $222 | 0.00% |
| Advisory Services Network, LLC | 74 | $164 | 0.00% |
| SRS Capital Advisors, Inc. | 55 | $122 | 0.00% |
Sold out (26)
Institutions that held C4 Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| AQR Capital Management LLC | 383,789 | $548.8K |
| Adage Capital Partners GP, L.L.C. | 200,000 | $286.0K |
| Atom Investors LP | 190,182 | $272.0K |
| Jain Global LLC | 136,219 | $194.8K |
| Aster Capital Management (DIFC) Ltd | 77,734 | $111.2K |
| HRT Financial LP | 71,106 | $101.0K |
| Y-Intercept (Hong Kong) Ltd | 52,521 | $75.1K |
| Brookstone Capital Management | 29,325 | $41.9K |
| Virtu Financial LLC | 24,377 | $35.0K |
| Bank of Montreal | 24,200 | $34.6K |
| Dynamic Technology Lab Private Ltd | 21,476 | $31.0K |
| Ieq Capital, LLC | 18,822 | $26.9K |
| Hudson Bay Capital Management LP | 16,095 | $23.0K |
| DRW Securities, LLC | 15,836 | $22.6K |
| Quadrature Capital Ltd | 13,547 | $19.3K |
| Gsa Capital Partners LLP | 10,963 | $16.0K |
| US Bancorp | 11,000 | $15.7K |
| Two Sigma Securities, LLC | 10,589 | $15.1K |
| Clear Street Markets LLC | 2,122 | $3.03K |
| Syntax Research, Inc. | 1,000 | $1.43K |
| Fortitude Family Office, LLC | 325 | $465 |
| EverSource Wealth Advisors, LLC | 310 | $444 |
| Skopos Labs, Inc. | 295 | $422 |
| Raymond James Financial Inc | 135 | $193 |
| Essential Partners LLC | 133 | $190 |
| True Wealth Design, LLC | 31 | $45 |